Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine)

NCT07691190 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

SCHIZOPHRENIA 1 (Disorder)

Interventions

DRUG: Cariprazine Hard Capsules
DRUG: Reagila® Hartkapseln (Hard Capsules) (Cariprazine)

Sponsor

Humanis Saglık Anonim Sirketi